[go: up one dir, main page]

AU6636800A - Heat shock fusion-based vaccine system - Google Patents

Heat shock fusion-based vaccine system

Info

Publication number
AU6636800A
AU6636800A AU66368/00A AU6636800A AU6636800A AU 6636800 A AU6636800 A AU 6636800A AU 66368/00 A AU66368/00 A AU 66368/00A AU 6636800 A AU6636800 A AU 6636800A AU 6636800 A AU6636800 A AU 6636800A
Authority
AU
Australia
Prior art keywords
heat shock
based vaccine
vaccine system
shock fusion
fusion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU66368/00A
Inventor
John Henry Kenten
Gerald Lohnas
Steven Roberts
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Proteinex Inc
Original Assignee
Proteinex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proteinex Inc filed Critical Proteinex Inc
Publication of AU6636800A publication Critical patent/AU6636800A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/77—Ovalbumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU66368/00A 1999-08-13 2000-08-14 Heat shock fusion-based vaccine system Abandoned AU6636800A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37472199A 1999-08-13 1999-08-13
US09374721 1999-08-13
PCT/US2000/022121 WO2001012216A1 (en) 1999-08-13 2000-08-14 Heat shock fusion-based vaccine system

Publications (1)

Publication Number Publication Date
AU6636800A true AU6636800A (en) 2001-03-13

Family

ID=23477956

Family Applications (1)

Application Number Title Priority Date Filing Date
AU66368/00A Abandoned AU6636800A (en) 1999-08-13 2000-08-14 Heat shock fusion-based vaccine system

Country Status (2)

Country Link
AU (1) AU6636800A (en)
WO (1) WO2001012216A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1608675B1 (en) 2003-03-28 2011-08-17 The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services Immunogenic hiv-1 multi-clade, multivalent constructs and methods of their use
CN105801704B (en) 2014-12-31 2020-06-02 艾托金生物医药（苏州）有限公司 Construction method and application of recombinant vaccine with anti-cervical cancer cell activity
CN110954706B (en) * 2019-11-20 2020-10-02 宁波三生生物科技有限公司 Method for measuring coupling rate of GnRH paralog dimer artificial antigen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1339684C (en) * 1988-05-17 1998-02-24 Peter H. Quail Plant ubquitin promoter system
US5840866A (en) * 1996-07-10 1998-11-24 Incyte Pharmaceuticals, Inc. Human ubiquitin-conjugating enzyme
DE19651443A1 (en) * 1996-12-11 1998-06-18 Hoechst Ag Self-reinforcing, pharmacologically controllable expression systems
US6007821A (en) * 1997-10-16 1999-12-28 Fordham University Method and compositions for the treatment of autoimmune disease using heat shock proteins

Also Published As

Publication number Publication date
WO2001012216A1 (en) 2001-02-22

Similar Documents

Publication Publication Date Title
AU2470499A (en) Heat shock fusion-based vaccine system
AU7837800A (en) Rapid infusion system
IL145045A0 (en) Vaccine
HUS1300072I1 (en) Vaccine
AU3637201A (en) Improved heat exchanger
AU5977700A (en) Vaccines
AU1380001A (en) Heat accumulator
AU1738201A (en) Adjuvants for nucleic acid vaccines
AU6158700A (en) Vaccine
AU6636800A (en) Heat shock fusion-based vaccine system
AU4957800A (en) Vaccine against isa virus
GB9906437D0 (en) Vaccine
AU1035901A (en) Transfer system
AU5811600A (en) Vaccine
AU7935000A (en) Heat storage system
AU5311200A (en) Cardioplegia heater/cooler system
AU5084300A (en) New vaccine formulations - 1
AU2153801A (en) Idiotype vaccines
GB9909072D0 (en) Vaccine
GB9922700D0 (en) Vaccine
AU4935700A (en) New vaccine formulations-3
AUPQ245999A0 (en) Vaccine strategy
AUPQ169199A0 (en) Heat dispelling system
AUPQ142899A0 (en) Low level heat recovery system
GB9915106D0 (en) Vaccine

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase